Ever and Current Commercial Tobacco and Nicotine Product Use in the United States: PATH Study Wave 7 Adult (2022-2023)

CRST and CAsToR collaborated to present weighted prevalence estimates from analyses of the Population Assessment of Tobacco and Health (PATH) Study, a national longitudinal study designed to be representative of the civilian noninstitutionalized US population. This brief presents results from Wave 7, which was fielded January 2022 through April 2023, and includes estimated prevalence of ever and current use of commercial tobacco products, as well as current commercial tobacco product use by demographic characteristics.